Dok-7 mutations underlie a neuromuscular junction synaptopathy.

Slični predmeti

• Clinical features of the DOK7 neuromuscular junction synaptopathy.
  od: Palace, J, i dr.
  Izdano: (2007)
• The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
  od: Beeson, D, i dr.
  Izdano: (2012)
• The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
  od: Cossins, J, i dr.
  Izdano: (2012)
• Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
  od: Arimura, S, i dr.
  Izdano: (2014)
• Congenital myasthenic syndromes and the formation of the neuromuscular junction.
  od: Beeson, D, i dr.
  Izdano: (2008)